629 related articles for article (PubMed ID: 18049312)
1. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Shen L
J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition by grape seed proanthocyanidin extracts of cell adhesion molecule expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Wu JM; Ma YB; You BA; Li BY; Xuan JH
J Cardiovasc Pharmacol; 2006 Aug; 48(2):47-53. PubMed ID: 16954821
[TBL] [Abstract][Full Text] [Related]
3. Grape seed proanthocyanidin extracts inhibit vascular cell adhesion molecule expression induced by advanced glycation end products through activation of peroxisome proliferators-activated receptor gamma.
Ma L; Gao HQ; Li BY; Ma YB; You BA; Zhang FL
J Cardiovasc Pharmacol; 2007 May; 49(5):293-8. PubMed ID: 17513948
[TBL] [Abstract][Full Text] [Related]
4. Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation.
Yamagishi S; Takeuchi M
Drugs Exp Clin Res; 2004; 30(4):169-75. PubMed ID: 15553663
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of grape seed proanthocyanidin extracts downregulate RAGE dependant nuclear factor- kappa BP65 expression in the hippocampus of streptozotocin induced diabetic rats.
Xu L; Li B; Cheng M; Zhang W; Pan J; Zhang C; Gao H
Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):215-24. PubMed ID: 18273752
[TBL] [Abstract][Full Text] [Related]
6. Minodronate, a nitrogen-containing bisphosphonate, inhibits advanced glycation end product-induced vascular cell adhesion molecule-1 expression in endothelial cells by suppressing reactive oxygen species generation.
Yamagishi S; Matsui T; Nakamura K; Takeuchi M
Int J Tissue React; 2005; 27(4):189-95. PubMed ID: 16440584
[TBL] [Abstract][Full Text] [Related]
7. Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species.
Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Okuda S; Imaizumi T
Ophthalmic Res; 2008; 40(1):10-5. PubMed ID: 18025836
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species.
Niiya Y; Abumiya T; Shichinohe H; Kuroda S; Kikuchi S; Ieko M; Yamagishi S; Takeuchi M; Sato T; Iwasaki Y
Brain Res; 2006 Sep; 1108(1):179-87. PubMed ID: 16872585
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells.
Chen J; Huang L; Song M; Yu S; Gao P; Jing J
J Cardiovasc Pharmacol; 2009 May; 53(5):359-67. PubMed ID: 19276989
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure.
Chello M; Spadaccio C; Lusini M; Covino E; Blarzino C; De Marco F; Di Domenico F; Coccia R
Diabetes Metab Res Rev; 2009 Jul; 25(5):420-6. PubMed ID: 19405075
[TBL] [Abstract][Full Text] [Related]
11. Expression of platelet-endothelial cell adhesion molecule-1 in human umbilical vein endothelial cells by exposure to advanced glycosylation end products and inflammatory mediators.
Meng D; Liu N
Chin Med J (Engl); 2003 Sep; 116(9):1336-40. PubMed ID: 14527361
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells.
Stitt AW; He C; Vlassara H
Biochem Biophys Res Commun; 1999 Mar; 256(3):549-56. PubMed ID: 10080935
[TBL] [Abstract][Full Text] [Related]
13. Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Fukami K; Okuda S; Imaizumi T
Microvasc Res; 2008 Jan; 75(1):130-4. PubMed ID: 17560613
[TBL] [Abstract][Full Text] [Related]
14. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
[TBL] [Abstract][Full Text] [Related]
15. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products.
Basta G; Lazzerini G; Del Turco S; Ratto GM; Schmidt AM; De Caterina R
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1401-7. PubMed ID: 15845907
[TBL] [Abstract][Full Text] [Related]
16. Sitagliptin augments protective effects of GLP-1 against advanced glycation end product receptor axis in endothelial cells.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2011 Sep; 43(10):731-4. PubMed ID: 21932180
[TBL] [Abstract][Full Text] [Related]
17. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
[TBL] [Abstract][Full Text] [Related]
18. The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products.
Mruthinti S; Sood A; Humphrey CL; Swamy-Mruthinti S; Buccafusco JJ
Neuroscience; 2006 Oct; 142(2):463-73. PubMed ID: 16890367
[TBL] [Abstract][Full Text] [Related]
19. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
